Literature DB >> 8263771

The P1-purinoceptors that mediate the prejunctional inhibitory effect of adenosine on capsaicin-sensitive nonadrenergic noncholinergic neurotransmission in the rat mesenteric arterial bed are of the A1 subtype.

A Rubino1, V Ralevic, G Burnstock.   

Abstract

It has been shown that capsaicin-sensitive sensory-motor nerves contribute to the control of peripheral vascular resistance by releasing the potent vasodilator calcitonin gene-related peptide. The purpose of the present study was to characterize the P1-purinoceptor subtype that modulates capsaicin-sensitive non-adrenergic noncholinergic (NANC) neurotransmission in the rat mesenteric arterial bed. Analogs of adenosine, selective for the adenosine receptor subtypes A1 or A2, were evaluated on the vasodilator response to electrical stimulation of capsaicin-sensitive sensory-motor nerves. The order of potency of adenosine receptor agonists to inhibit the NANC neurotransmission was: the selective adenosine A1 receptor agonist N6cyclopentyl-adenosine > or = R-phenylisopropyladenosine > 5'N-ethylcarboxamide adenosine > or = 2-chloroadenosine > or = S-phenylisopropyladenosine. The A2-selective agonist CGS 21680 was devoid of any effect on NANC neurotransmission. In addition, the selective A1 receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine inhibited the effect of adenosine. None of the agonists tested showed direct action on the tone of the mesenteric vasculature. Neither N6cyclopentyladenosine nor adenosine modified the vasodilator response to exogenous calcitonin gene-related peptide. Moreover, adenosine failed to affect the vasodilator response to capsaicin. In conclusion, these results indicate that adenosine and its analogs inhibit NANC neurotransmission via prejunctional P1-purinoceptors of the A1 subtype. The inhibitory action of adenosine appears to be selective for the release of transmitters during electrical activation of sensory-motor nerve endings, adenosine being inactive on capsaicin-induced vasodilatation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263771

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

2.  Mechanism of prolonged vasorelaxation to ATP in the rat isolated mesenteric arterial bed.

Authors:  V Ralevic
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

3.  Effects of NAD at purine receptors in isolated blood vessels.

Authors:  E Alefishat; S P H Alexander; V Ralevic
Journal:  Purinergic Signal       Date:  2014-10-15       Impact factor: 3.765

4.  Adenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NO.

Authors:  P Nieri; E Martinotti; V Calderone; M C Breschi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  Modulation by nicotinamide adenine dinucleotide of sympathetic and sensory-motor neurotransmission via P1-purinoceptors in the rat mesenteric arterial bed.

Authors:  V Ralevic
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.

Authors:  Marnie Duncan; Paul Millns; Darren Smart; James E Wright; David A Kendall; Vera Ralevic
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

7.  Augmented sensory-motor vasodilatation of the rat mesenteric arterial bed after chronic infusion of the P1-purinoceptor antagonist, DPSPX.

Authors:  V Relevic; A Rubino; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

8.  Purinergic receptors in the splanchnic circulation.

Authors:  Manuela Morato; Teresa Sousa; António Albino-Teixeira
Journal:  Purinergic Signal       Date:  2008-04-29       Impact factor: 3.765

9.  Contribution of P1-(A2b subtype) and P2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed.

Authors:  A Rubino; V Ralevic; G Burnstock
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

Review 10.  Understanding gastrointestinal perfusion in critical care: so near, and yet so far.

Authors:  G Ackland; M P Grocott; M G Mythen
Journal:  Crit Care       Date:  2000-09-01       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.